Letter/Communication
A New Dawn for Hemophilia A? Lentiviral Gene Therapy Using Autologous Stem Cells
NEJM journal watch. Oncology & hematology
12/18/2024
Abstract
An innovative approach of delivering gene therapy via hematopoietic stem cells could revolutionize hemophilia A treatment by providing a one-time intervention with lasting effects.
Details
- Title: Subtitle
- A New Dawn for Hemophilia A? Lentiviral Gene Therapy Using Autologous Stem Cells
- Creators
- Anjali Sharathkumar
- Resource Type
- Letter/Communication
- Publication Details
- NEJM journal watch. Oncology & hematology
- Publisher
- Massachusetts Medical Society
- ISSN
- 2330-0426
- Language
- English
- Date published
- 12/18/2024
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984758181702771
Metrics
7 Record Views